EIN 45-0524687

Foundation Fighting Blindness Retinal Degeneration Fund

IRS 501(c) type
501(c)(3)
Num. employees
10
Year formed
2003
Most recent tax filings
2023-06-01
Description
The Foundation Fighting Blindness Retinal Degeneration Fund's mission accelerates the translation of retinal laboratory-based research into clinical trials to expedite the commercialization of patient therapies. Three largest program services accomplishments in fiscal 2023 were equity investments in Opus Genetics, Perceive Bio, and Amber Bio.
Related structure
Foundation Fighting Blindness Retinal Degeneration Fund is a subordinate organization under Foundation Fighting Blindness (FFB).
Also known as...
Foundation Fighting Blindness Clinical Research Institute; National Neurovision Research Institute
Total revenues
$9,316,837
2023
Total expenses
$1,014,874
2023
Total assets
$47,303,067
2023
Num. employees
10
2023

Program areas at Foundation Fighting Blindness Retinal Degeneration Fund

The three largest program services accomplishments (as measured by expenses) for the Foundation Fighting Blindness Retinal Degeneration Fund (ffb-rdf) during fiscal 2023 were equity investments in opus genetics, perceive bio, and amber bio. Opus genetics and perceive bio are both clinically staged gene therapy companies, and amber bio is a preclinical stage company. Each of these companies is focused on advancing promising therapies for Retinal degenerative diseases.fiscal 2023 summary:ffb-rdf invested an additional $7,000,000 in opus genetics to help advance its pipeline of orphan inherited Retinal disease indications including lca5, best1, rdh12 and mertk. The first patient was dosed in the lca5 phase i/ii clinical trial in august 2023. Ffb-rdf invested $2,564,098 in perceive bio to help advance a clinical-stage complement factor h gene therapy program for the treatment of dry amd, and an early staged dual leucine kinase-dependent inhibitor program aimed at axonal neuroprotection for the treatment of glaucoma and Retinal diseases.ffb-rdf invested $1,800,000 in amber bio to help support the development of an rna editing platform that will be first applied to Retinal degenerative diseases.

Who funds Foundation Fighting Blindness Retinal Degeneration Fund

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Foundation Fighting Blindness (FFB)Research$14,920,274
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$12,908
Morgan Stanley Global Impact Funding TrustUnrestricted General Support$10,000
...and 1 more grant received

Personnel at Foundation Fighting Blindness Retinal Degeneration Fund

NameTitleCompensation
Jason MenzoChief Executive Officer$91,780
Peter GinsbergChief Operating Officer$66,023
Jeff KlaasChief Strategy and Innovation Officer
Judy TaylorSenior Vice President , Chief Development Officer
Rishi DonatChief Human Resources Officer
...and 17 more key personnel

Financials for Foundation Fighting Blindness Retinal Degeneration Fund

RevenuesFYE 06/2023
Total grants, contributions, etc.$14,920,274
Program services$0
Investment income and dividends$0
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$-5,603,437
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$9,316,837

Form 990s for Foundation Fighting Blindness Retinal Degeneration Fund

Fiscal year endingDate received by IRSFormPDF link
2023-062023-11-02990View PDF
2022-062023-11-02990View PDF
2022-062022-11-02990View PDF
2021-062021-11-11990View PDF
2020-062021-02-26990View PDF
...and 10 more Form 990s
Data update history
October 4, 2024
Updated personnel
Identified 8 new personnel
January 21, 2024
Updated personnel
Identified 4 new personnel
January 9, 2024
Posted financials
Added Form 990 for fiscal year 2023
December 30, 2023
Received grants
Identified 1 new grant, including a grant for $14,920,274 from Foundation Fighting Blindness (FFB)
July 14, 2023
Posted financials
Added Form 990 for fiscal year 2022
Nonprofit Types
Grantmaking organizationsDisease research fundraisersDisease-focused nonprofitsChapter / child organizationsCharities
Issues
HealthDiseases and disorders
Characteristics
Conducts researchOperates internationallyReceives government fundingTax deductible donationsAccepts online donations
General information
Address
6925 Oakland Mills Rd 701
Columbia, MD 21045
Metro area
Baltimore-Columbia-Towson, MD
County
Howard County, MD
Website URL
retinaldegenerationfund.org/ 
Phone
(410) 423-0600
IRS details
EIN
45-0524687
Fiscal year end
June
Taxreturn type
Form 990
Year formed
2003
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
G40: Diseases of Specific Organs
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Subordinate organization
Free account sign-up

Want updates when Foundation Fighting Blindness Retinal Degeneration Fund has new information, or want to find more organizations like Foundation Fighting Blindness Retinal Degeneration Fund?

Create free Cause IQ account